What We're Reading: Page 155
Industry reads hand-picked by our editors
Oct 29, 2021
-
Science
2021’s Top Employers engage, nurture, and harness the power of scientists
-
Politico
‘Bereft’: How Operation Warp Speed’s decisions left the world waiting for a vaccine
-
Business Insider
Regeneron's top scientist George Yancopoulos tells us the one big thing he thinks gene-editing biotechs are doing wrong
-
Fierce Biotech
Frazier has raised an $830M public life science fund. Here's how it plans to invest the cash
Oct 28, 2021
-
Science
The pandemic turned them into celebrities. Now scientists are grappling with new power—and internet hate
-
BioCentury
How Woodcock has changed FDA
-
The New York Times
A cheap antidepressant lowers the risk of Covid hospitalization, a large study finds.
-
The Boston Globe
As labs replace offices across Greater Boston, pushback is mounting from wary neighbors
Previous
